EU Approves AstraZeneca’s Imfinzi for Bladder Cancer, Because Apparently Chemo Alone Wasn’t Bleak Enough
AstraZeneca’s Imfinzi has officially been approved in the European Union for the treatment of muscle-invasive bladder cancer…
AstraZeneca’s $1 Billion Cell Therapy Acquisition
AstraZeneca acquires EsoBiotec to revolutionize cancer and immune disease therapies.
Untapped: $20.4M Fund Boosts AI in Oncology Revolution
Ataraxis AI, a trailblazer in AI-powered precision medicine, has secured $20.4 million in Series A funding, positioning…
